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Aim 
Photobiomodulation (PBMT) therapy has proved to be effective for a wide range of oral 
pathologies including oral dryness, but the literature still lacks reports of clinical trials and 
protocols. The purpose of our study was to evaluate the effects of different wavelengths of 
PBMT on salivation in patients suffering from hyposalivation aiming at determination of 
optimal treatment protocol. 
Materials and  methods 
This study included 30 patients whose major salivary glands were treated with low intensity 
diode laser BTL2000 (Medical Technologies, s.r.o., Czech Republic) during 10 consecutive 
days. Patients were randomly assigned in two groups, each of 15 patients, and treated with 
PBMT of 830 nm and PBMT of 685 nm, respectively. The whole unstimulated and 
stimulated saliva was measured each day during 10 days, before and after laser treatment and 
10th day after treatment was ended.  
Results 
Results have shown that the laser treatment significantly improves salivation (p<0.0001) in 
both groups after 10-days treatment. The salivation also remains improved 10 days after the 
end of the treatment. The patients treated with PBMT of 830 nm have had continuously 
higher values of quantity of saliva. 
Conclusion 
Our results have shown that both laser wave-lengths were effective in increasing salivary 
flow rate, and the improvement in salivation was statistically significant. The effect of 
treatment could be observed 10 days after the completion of the treatment thus providing 
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evidence not only of stimulative effect but also indicating regenerative potential of 
photobiomodulation  therapy.  
 
Introduction 
 
Xerostomia is an often complaint mainly in elderly population, resulting with difficulties in 
speaking, food swallowing and tasting, denture wearing, burning sensations in the mouth and 
increased susceptibility of oral mucosa to diseases
1
. Although the lack of saliva seriously 
impairs the quality of life, it is often neglected. Etiology of xerostomia is different, varying 
from salivary gland disease, systemic diseases, radiation therapy or, the most frequently, 
drug-induced xerostomia
2–5
. Increasing salivary flow (in case acinar cells are preserved) 
represents the best therapy, but gustatory stimulation is short-acting and must be often 
repeated
6,7
. Other therapeutic models include use of systemic sialogogues, electrical 
stimulation, acupuncture
3
, and use of saliva substitutes
5
. Each of these methods has some 
limitations, as described in our previous work
8
. Many different artificial saliva products on 
the market are of limited value in the treatment of xerostomia. Although convenient and 
simple, some patients find gustatory stimulation debilitating and tiresome. Systemic 
cholinergic agents such as pilocarpine and cevimeline increase salivary flow rate, but have 
side effects and certain contraindications
5
. 
 
Low level laser treatment, more recently termed photobiomodulation (PBM), has proved to 
be effective for a wide range of oral pathologies including oral dryness, but the literature still 
lacks reports of clinical trials and protocols. Photobiomodulation (PBMT) therapy induces 
changes in the cellular redox state and pH homeostasis
9
, increases ATP production in the 
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cell
10,11
 and converts laser light energy input through biochemical and photophysical 
processes into energy useful to the cell
12
.  
In our previous study 
8
 we have reported the efficacy of PBMT for the treatment of 
xerostomia providing good therapeutic results. Since then, we have introduced a new laser 
device and performed research with two different wavelengths in patients with 
hyposalivation. The aim was to evaluate the effects of these new laser wavelengths, different 
from those used in previous research, on salivation of patients suffering from hyposalivation. 
This with purpose to possibly find the optimum laser wavelength for the treatment, and to 
determine the better protocol for the patients suffering from hyposalivation.  
 
Materials and methods 
The study included 30 consent female patients (age range 52-85y, mean age 69.6, median 72) 
whose major salivary glands were treated with low intensity diode laser (BTL-2000 Medical 
Technologies, Prague, BTL Co., Czech Rep.). The nominal output of the probes were 30  
mW at 685 nm and 100 mW at 830 nm and set at a pulse repetition rate of 5.2 Hz to deliver 
30 mW at 685 nm and 35 mW at 830 nm. The power measurements were provided by the  
manufacturer. operating in a pulse mode at a frequency of 5.20 Hz and delivering a 30 mW 
power output at 685 nm and 35 mW power output at 830 nm. The treatment was performed 
during 10 consecutive days, with a laser probe. During application, protective eyeglasses 
were worn both by the operator and the patient. The patients were divided in two groups; the 
first group comprised 15 female patients (age range 52-77 years, mean age 69.53, median 72) 
which were treated with 830 nm laser wavelength. The second group comprised 15 female 
patients (age range 55-85 years, mean age 67.67, median 72) which were treated with 685 nm 
laser wavelength. To establish the diagnosis of hyposalivation, the amount of total 
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unstimulated saliva was measured at the initial examination of the patients. After that the 
salivation was stimulated with citric acid. Photobiomodulation therapy was not started at the 
initial examination of the patient to avoid any possible error in the measurement of saliva 
quantity after different types of stimulation. The photobiomodulation therapy began on the 
next day.  
The total unstimulated and stimulated saliva quantities were measured before and after each 
laser treatment and 10 days after the last (10
th
) treatment, to determine the durability of 
results. Patients were asked to expectorate all saliva into graduated test tubes for a 5-min 
period. The amount of saliva was determined by the scale on the graduated tubes. 
The inclusion criteria for all patients were medical histories free of radiotherapy and 
Sjögren’s syndrome. Sjögren’s syndrome was excluded by the applied diagnostic criteria
13
. In 
all patients clinical examination and sialometry was done and anamnestic data (drug history) 
were taken. Our research was approved by the Ethical Committee of our faculty and 
registered at U.S. National Institutes of Health (trial identifier: NCT03049943). All patients 
signed informed consent to participate in the study.  
The laser beam was applied bilaterally to each salivary gland area, extraorally to the parotid 
and submandibular glands and intraorally to the sublingual gland (each patient received a 
total of six exposures, each of different duration depending of the gland and laser wavelength 
which was predetermined by the laser settings. The treatment lasted for 10 consecutive days. 
The distance between the probe and the irradiated area was kept constant at 0.5 cm 
throughout the treatment period. The spot size was difficult to calculate due to slight 
difference from the irradiated area so it was estimated. The laser probe was not held 
stationary, but moved around in mesh-shaped movements. This technique is recommended 
for manual scanning to ensure that a reasonably uniform dosage is delivered to all areas of the 
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treated surface
14
. The relevant technical data for the photobiomodulation therapy are given in 
Table 1. 
Statistical methods, including correlation analysis, t-test and repeated measures ANOVA 
(with Bonferroni's multiple comparison post-hoc test) were used for comparison and 
interpretation of the difference in salivary flow rates between the two groups. 
 
Results 
The average salivary flow rates obtained from the both laser wavelength groups before and 
after PBMT throughout the 10-day treatment period and 10 days after the last (10
th
) treatment 
are shown in Figure 1. If we compare the results by the laser wavelength, we can see that the 
patients in the 830 nm laser wavelength group have higher values of saliva stimulation 
throughout the study than the patients in the 685 nm laser wavelength group. 
 
The comparison of average measured salivary flow rate before the laser treatment on the first 
day with that on the last day of the treatment series shows significantly higher rate for both 
laser groups of patients and for all patients (T-test for paired examples, p = 0.0044 (685 nm), 
p = 0.0019 (830 nm), p<0.0001 (all patients)) (Fig. 2.). Also the comparison of average 
measured salivary flow rate before the laser treatment on the first day with that measured 10 
days after the end of the treatment, shows that the salivation was significantly increased for 
all patients (T-test for paired examples,  p=0.0009) and each group of patients (p = 0.0121 
(685 nm), p = 0.0347 (830 nm)) (Fig. 3.). The results were also statistically significant by 
repeated measurements ANOVA testing (all patients p<0.0001; 685 nm laser p=0.001; 830 
nm laser p<0.0001). However, Bonferroni's multiple comparison post test only confirmed the 
significance of salivary flow rate differences between the first day and last day of the 
treatment for 830 nm laser (p<0.01). The difference between first day and 10
th
 day after 
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treatment did not reach statistical significance together with same comparisons for 685 nm 
laser. 
 
Discussion 
Our results show that treatment with both laser wavelengths, 830 nm and 685 nm, was 
effective in improving the salivary flow rate. After ten days of treatment in each treated group 
of patients the average salivary flow rate was significantly higher. The treatment with 
wavelength of 830 nm was more effective resulting in a higher average increase of salivation. 
The observed difference in efficiency of 830 nm and 685 nm (at the same applied energy 
level) could be attributed to different spectral absorption properties of the oral soft tissue’s 
main chromophores, in particular water and oxyhemoglobin. Namely, the absorption 
coefficient of water (comprising about 75% of the tissue) is approximately five times higher 
at 830 nm than at 685 nm while for oxyhemoglobin the difference in absorption coefficients 
is about 25%
15,16
. 
By comparing the differences in saliva stimulation in each group for 10 consecutive days of 
treatment, we can see that the response of the gland to the same amount of applied energy 
was not constant. Unlike our previous study
8
, we didn’t observe linear increase in salivation 
flow during the treatment. Rather, after initial significant increase in first few days of 
treatment, it remained, with slight oscillations, at a relatively constant value. The salivation in 
both groups on the last day of treatment and 10 days after the end of the treatment was 
improved, in comparison to the unstimulated whole saliva at the first day of treatment before 
beginning of photobiomodulation PBM therapy, and this difference is statistically significant. 
The salivation remained improved for prolonged time as documented with measurements 
accomplished ten days after the end of treatment. This improvement in the salivation rate, 
although somewhat lower than the increase observed during the treatment, is important 
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because it indicates that this type of therapy does not have only short-term effect, but has also 
the regenerative effect on salivary glands as their function remains restored for a certain time 
after the completion of the therapy. In recent years, the regenerative effect of PBMT was 
described in the literature for treatment of muscle repair
17,18
, wound healing
19,20
, 
mesenchymal stromal cells therapies
21
 and xerostomia
8
. Our results also confirm the 
biostimulative and regenerative effect of PBMT, due to restoring salivary glands function, 
which remained improved at least ten days after the termination of the photobiomodulation 
PBM therapy. In this context it would be intriguing to see whether an occasional 
photobiomodulation PBM therapy would help to maintain the achieved amount of salivation 
on constant level, which would be a great advantage of this type of hyposalivation treatment. 
Regarding the effects of medication on salivation in the literature one can find many studies 
reporting decrease of salivary flow rate due to use of various drugs
2,22-24
. Since all of our 
patients were taking medication for their other health conditions, we could assume that the 
xerogenic effect of the used drugs, with prolonged time after the completion of the therapy 
inhibits salivation, causing hyposalivation. Despite this possible negative influence of used 
drugs our investigation proved the effectiveness of the 830 nm and 685 nm 
photobiomodulation therapy in stimulation of salivation.  
Since the world population of elderly people is increasing and polytherapy (taking multiple 
medications) is becoming more and more frequent in general population, it is important to 
find efficient therapy for hyposalivation which doesn’t have side effects and gives the best 
results. In this context it is important to emphasize that none of the patients included in this 
study reported any side-effects from this type of therapy. Literature offers many positive 
results of photobiomodulation for treatment of decreased salivary flow rate
8,25–29
, but with 
different laser parameters and treatment protocol. Searching the literature, we didn’t find 
published research on patients with hyposalivation similar to ours, so we could not compare 
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our results with those from other studies. In comparison with our previous study where we 
have applied 904 nm wavelength on salivary glands
8
, along with these results, we can 
confirm better therapeutic response of wavelengths in infra-red part of spectrum. 
 
Conclusion 
We have investigated the effects of PBMT with wavelengths 830 nm and 685 nm on 
salivation in patients suffering from hyposalivation. 
Our results have shown that both laser wavelengths with selected exposure times were 
effective in increasing salivary flow rate, and that the improvement in salivation was 
significant. Although the difference between the two laser groups was not statistically highly 
significant, the 830 nm laser wavelength proved to be more effective in stimulating the 
salivation. This difference could be attributed to the different spectral absorption properties of 
the oral soft tissue’s main chromophores. The positive effect of the photobiomodulation 
therapy could be observed 10 days after the completion of the treatment, with better 
maintained effect of 830 nm wavelength. Thus, indicating a regenerative potential of this type 
of therapy which should be further investigated and compared with other therapeutic options 
for hyposalivation.  
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Table 1. The relevant technical data for the laser therapy 
 
Salivary gland Laser specifications 685 nm 830 nm 
parotide gland 
Dose (J/cm2) 
1.80 1.80  
  
  
  
  
Power (mW) 
30  35  
Area (cm2) 
4.00  4.00  
Applied energy (J) 
9 8.995 
Power density (W/cm2) 
0.0075 0.00875 
Distance (cm) 
0.5 0.5 
Time (m:s) 
5:00 4:17  
Max. power (mW) 
30  35  
Frequency (Hz) 
5.20 5.20 
Number of treatments 
10 10 
Cumulative dose given 
(J/cm2) 18.0 18.0 
submandibular gland 
Dose (J/cm2) 
1.80  1.80  
Power (mW) 
30 35 
Area (cm2) 
1.60 1.60  
 
Applied energy (J) 
3.6 3.605 
Power density (W/cm2) 
0.01875 0.021875 
Distance (cm) 
0.5 0.5 
Time (m:s) 
2:00  1:43 
Max. power (mW) 
30 35  
Frequency (Hz) 
5.20 5.20 
Number of treatments 
10 10 
Cumulative dose given 
(J/cm2) 18.0 18.0 
sublingual gland 
Dose (J/cm2) 
1.80  1.80  
Power (mW) 
30 35 
Area (cm2) 
0.80  0.80  
 
Applied energy (J) 
1.8 1.785 
Power density (W/cm2) 
0.0375 0.04375 
Distance (cm) 
0.5  0.5 
Time (m:s) 1:00  0:51  
Max. power (mW) 30  35  
Frequency (Hz) 5.20 5.20 
Number of treatments 10 10 
Cumulative dose given 
(J/cm2) 18.0 18.0 
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Figure 1. Average measured mean saliva flow rate in groups treated with different lasers: BL= before the 
laser treatment, AL= after the laser treatment and 10 days after the completion of treatment series (NS ).  
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Figure 2.  The difference in measured whole unstimulated saliva flow rate (BL-before the laser treatment) on 
the first and on the last day of the treatment.  BL d1= unstimulated saliva flow rate at the first day of 
treatment, before laser treatment; BL d10= unstimulated saliva flow rate before laser treatment on the 10th 
day of treatment (T-test for paired examples, p = 0.0044 (685 nm), p = 0.0019 (830 nm), p<0.0001 (all 
patients )).  
 
211x159mm (96 x 96 DPI)  
 
 
Page 17 of 21
Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801
Photomedicine and Laser Surgery
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only/Not for Distribution
  
 
 
Figure 3. The difference in measured whole unstimulated saliva flow rate before the laser treatment on the 
first day of the treatment (BL d1) and ten days after the end of the treatment. BL d1=salivary flow rate 
before laser therapy on the first day; NS 10+= salivary flow rate 10 days after the completion of the laser 
therapy (T-test for paired examples,  p = 0.0121 (685 nm), p = 0.0347 (830 nm) and all patients 
(p=0.0009)).  
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Figure legends 
Figure 1. Average measured mean saliva flow rate in groups treated with different lasers: BL= 
before the laser treatment, AL= after the laser treatment and 10 days after the completion of 
treatment series (NS ). 
Figure 2.  The difference in measured whole unstimulated saliva flow rate (BL-before the 
laser treatment) on the first and on the last day of the treatment.  BL d1= unstimulated saliva 
flow rate at the first day of treatment, before laser treatment; BL d10= unstimulated saliva 
flow rate before laser treatment on the 10th day of treatment (T-test for paired examples, p = 
0.0044 (685 nm), p = 0.0019 (830 nm), p<0.0001 (all patients )). 
Figure 3. The difference in measured whole unstimulated saliva flow rate before the laser 
treatment on the first day of the treatment (BL d1) and ten days after the end of the treatment. 
BL d1=salivary flow rate before laser therapy on the first day; NS 10+= salivary flow rate 10 
days after the completion of the laser therapy (T-test for paired examples,  p = 0.0121 (685 
nm), p = 0.0347 (830 nm) and all patients (p=0.0009)). 
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